The Michigan Radiation Oncology Quality Consortium (MROQC) is a Blue Cross Blue Shield of Michigan-Blue Care Network (BCBSM-BCN) sponsored Collaborative Quality Initiative (CQI). It comprises 25 Radiation Oncology academic and community practice facilities across Michigan, working together to identify best practices and guide the appropriate use of high-cost technology in radiation treatment. Since its inception in 2011, MROQC has collected real-world, real-time prospective data for nearly 40,000 patients spanning breast, lung, prostate cancers, and bone metastases. Unlike clinical trial data, which can take years to implement, real-world data provides immediate, actionable insights. This session will demonstrate how MROQC integrates patient-reported (PROs) and physician-reported outcomes to bridge the gap between research and clinical practice. It will also explore how payer-provider collaborations support a sustainable framework for quality improvement. Attendees will leave with practical strategies to enhance patient care using real-world data, along with insights on overcoming barriers to implementing quality metrics and achieving equity across diverse populations.

Topics:

1. Dual Energy CT and SPECT for Functional Lung Assessment
   Houda Bahig, MD, PhD
2. Implementation of Quantitative Imaging Modalities for Brain Tumors to Guide RT Targeting 
   Hui-Kuo George Shu, MD, PhD, FASTRO 
3. V/Q PET for Functional Lung Assessment and Avoidance 
   Nicholas Bucknell, MBBS 
4. Development of "Personalized Radiotherapy" Techniques through the Incorporation of Novel Imaging Methodologies 
   Clifton David Fuller, MD, PhD
5. QA Issues with Widespread Implementation of Quantitative Imaging Modalities  
   Michael V Knopp, MD, PhD

This activity is available from January 16, 2024, through 11:59 p.m. Eastern time on December 31, 2025. 

This activity was originally recorded at the 2025 ASTRO Annual Meeting.

This activity does not offer continuing medical education credit.